FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808793886> ?p ?o ?g. }

• W2808793886 endingPage "28624" @default.
• W2808793886 startingPage "28612" @default.
• W2808793886 abstract "// Laura Barrio-Real 1, * , Cynthia Lopez-Haber 1, * , Victoria Casado-Medrano 1 , Alexander G. Goglia 2 , Jared E. Toettcher 2 , Maria J. Caloca 3 and Marcelo G. Kazanietz 1 1 Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA 2 Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014, USA 3 Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas, Universidad de Valladolid, 47003 Valladolid, Spain * These authors contributed equally to this work Correspondence to: Marcelo G. Kazanietz, email: marcelog@upenn.edu Keywords: P-Rex1; Rac1; Erk; Akt; mitogenesis Received: November 27, 2017      Accepted: May 19, 2018      Published: June 19, 2018 ABSTRACT Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (P-Rex1) is a key mediator of growth factor-induced activation of Rac1, a small GTP-binding protein widely implicated in actin cytoskeleton reorganization. This Guanine nucleotide Exchange Factor (GEF) is overexpressed in human luminal breast cancer, and its expression associates with disease progression, metastatic dissemination and poor outcome. Despite the established contribution of P-Rex1 to Rac activation and cell locomotion, whether this Rac-GEF has any relevant role in mitogenesis has been a subject of controversy. To tackle the discrepancies among various reports, we carried out an exhaustive analysis of the potential involvement of P-Rex1 on the activation of the mitogenic Erk pathway. Using a range of luminal breast cancer cellular models, we unequivocally showed that silencing P-Rex1 (transiently, stably, using multiple siRNA sequences) had no effect on the phospho-Erk response upon stimulation with growth factors (EGF, heregulin, IGF-I) or a GPCR ligand (SDF-1). The lack of involvement of P-Rex1 in Erk activation was confirmed at the single cell level using a fluorescent biosensor of Erk kinase activity. Depletion of P-Rex1 from breast cancer cells failed to affect cell cycle progression, cyclin D1 induction, Akt activation and apoptotic responses. In addition, mammary-specific P-Rex1 transgenic mice (MMTV-P-Rex1) did not show any obvious hyperproliferative phenotype. Therefore, despite its crucial role in Rac1 activation and cell motility, P-Rex1 is dispensable for mitogenic or survival responses in breast cancer cells." @default.
• W2808793886 created "2018-06-29" @default.
• W2808793886 creator A5003929468 @default.
• W2808793886 creator A5029548499 @default.
• W2808793886 creator A5029795371 @default.
• W2808793886 creator A5032888046 @default.
• W2808793886 creator A5049702760 @default.
• W2808793886 creator A5084426142 @default.
• W2808793886 date "2018-06-19" @default.
• W2808793886 modified "2023-09-24" @default.
• W2808793886 title "P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer" @default.
• W2808793886 cites W1480194729 @default.
• W2808793886 cites W1575979150 @default.
• W2808793886 cites W1967035754 @default.
• W2808793886 cites W1973470243 @default.
• W2808793886 cites W1974917583 @default.
• W2808793886 cites W1979629373 @default.
• W2808793886 cites W1981573832 @default.
• W2808793886 cites W1985066088 @default.
• W2808793886 cites W1989220634 @default.
• W2808793886 cites W1991777734 @default.
• W2808793886 cites W1991887088 @default.
• W2808793886 cites W2006860571 @default.
• W2808793886 cites W2009556803 @default.
• W2808793886 cites W2012340331 @default.
• W2808793886 cites W2012843157 @default.
• W2808793886 cites W2020733170 @default.
• W2808793886 cites W2021170096 @default.
• W2808793886 cites W2034983118 @default.
• W2808793886 cites W2035000040 @default.
• W2808793886 cites W2042264070 @default.
• W2808793886 cites W2045976797 @default.
• W2808793886 cites W2047276626 @default.
• W2808793886 cites W2050573392 @default.
• W2808793886 cites W2055808017 @default.
• W2808793886 cites W2057547217 @default.
• W2808793886 cites W2060630008 @default.
• W2808793886 cites W2072836988 @default.
• W2808793886 cites W2074075635 @default.
• W2808793886 cites W2074403146 @default.
• W2808793886 cites W2079816467 @default.
• W2808793886 cites W2089091109 @default.
• W2808793886 cites W2090965882 @default.
• W2808793886 cites W2096790979 @default.
• W2808793886 cites W2102312968 @default.
• W2808793886 cites W2106354709 @default.
• W2808793886 cites W2137022580 @default.
• W2808793886 cites W2146473598 @default.
• W2808793886 cites W2163119252 @default.
• W2808793886 cites W2163430198 @default.
• W2808793886 cites W2164767056 @default.
• W2808793886 cites W2168979150 @default.
• W2808793886 cites W2468580854 @default.
• W2808793886 cites W2472397433 @default.
• W2808793886 cites W2504530590 @default.
• W2808793886 cites W2507693146 @default.
• W2808793886 cites W2508162736 @default.
• W2808793886 cites W2563000383 @default.
• W2808793886 cites W2736838547 @default.
• W2808793886 cites W4239945442 @default.
• W2808793886 doi "https://doi.org/10.18632/oncotarget.25584" @default.
• W2808793886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6033363" @default.
• W2808793886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29983884" @default.
• W2808793886 hasPublicationYear "2018" @default.
• W2808793886 type Work @default.
• W2808793886 sameAs 2808793886 @default.
• W2808793886 citedByCount "8" @default.
• W2808793886 countsByYear W28087938862018 @default.
• W2808793886 countsByYear W28087938862019 @default.
• W2808793886 countsByYear W28087938862020 @default.
• W2808793886 countsByYear W28087938862021 @default.
• W2808793886 countsByYear W28087938862023 @default.
• W2808793886 crossrefType "journal-article" @default.
• W2808793886 hasAuthorship W2808793886A5003929468 @default.
• W2808793886 hasAuthorship W2808793886A5029548499 @default.
• W2808793886 hasAuthorship W2808793886A5029795371 @default.
• W2808793886 hasAuthorship W2808793886A5032888046 @default.
• W2808793886 hasAuthorship W2808793886A5049702760 @default.
• W2808793886 hasAuthorship W2808793886A5084426142 @default.
• W2808793886 hasBestOaLocation W28087938861 @default.
• W2808793886 hasConcept C121608353 @default.
• W2808793886 hasConcept C126322002 @default.
• W2808793886 hasConcept C126619667 @default.
• W2808793886 hasConcept C185592680 @default.
• W2808793886 hasConcept C2776179587 @default.
• W2808793886 hasConcept C2779717556 @default.
• W2808793886 hasConcept C502942594 @default.
• W2808793886 hasConcept C530470458 @default.
• W2808793886 hasConcept C57074206 @default.
• W2808793886 hasConcept C62478195 @default.
• W2808793886 hasConcept C71924100 @default.
• W2808793886 hasConcept C75217442 @default.
• W2808793886 hasConcept C86554907 @default.
• W2808793886 hasConcept C86803240 @default.
• W2808793886 hasConcept C95444343 @default.
• W2808793886 hasConceptScore W2808793886C121608353 @default.
• W2808793886 hasConceptScore W2808793886C126322002 @default.
• W2808793886 hasConceptScore W2808793886C126619667 @default.

• next